MX2020005101A - Absorbente para tratamiento de heridas. - Google Patents

Absorbente para tratamiento de heridas.

Info

Publication number
MX2020005101A
MX2020005101A MX2020005101A MX2020005101A MX2020005101A MX 2020005101 A MX2020005101 A MX 2020005101A MX 2020005101 A MX2020005101 A MX 2020005101A MX 2020005101 A MX2020005101 A MX 2020005101A MX 2020005101 A MX2020005101 A MX 2020005101A
Authority
MX
Mexico
Prior art keywords
hemostatic composition
hemostatic
wound
degree
crosslinking
Prior art date
Application number
MX2020005101A
Other languages
English (en)
Inventor
Vadim Valerievich Krongauz
Wei Xie
Michael Tung Kiung Ling
Original Assignee
Baxter Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Int filed Critical Baxter Int
Publication of MX2020005101A publication Critical patent/MX2020005101A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0023—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A61L26/0042—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/008—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A61L2300/254—Enzymes, proenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/406—Antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A61L2300/414—Growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/428—Vitamins, e.g. tocopherol, riboflavin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/80—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special chemical form
    • A61L2300/802—Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Materials Engineering (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente divulgación provee kits absorbentes para el tratamiento de heridas que comprenden una serie de composiciones hemostáticas que incluyen por lo menos (1) una primera composición hemostática que incluye un primer polisacárido reticulado seleccionado del grupo que consiste en ciclodextrina y dextrano, y (2) una segunda composición hemostática que incluye un segundo polisacárido reticulado seleccionado del grupo que consiste en ciclodextrina y dextrano. En algunas modalidades, la primera composición hemostática tiene un primer grado de reticulación y la segunda composición hemostática tiene un segundo grado de reticulación mayor que el primer grado de reticulación. También se proveen métodos de tratamiento de una herida mediante la selección de una composición hemostática de la serie de composición hemostáticas divulgadas, y la administración de la composición hemostática seleccionada a un sitio de la herida.
MX2020005101A 2017-11-28 2018-11-27 Absorbente para tratamiento de heridas. MX2020005101A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762591481P 2017-11-28 2017-11-28
PCT/US2018/062513 WO2019108497A1 (en) 2017-11-28 2018-11-27 Wound-treating absorbent

Publications (1)

Publication Number Publication Date
MX2020005101A true MX2020005101A (es) 2020-09-09

Family

ID=64664521

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020005101A MX2020005101A (es) 2017-11-28 2018-11-27 Absorbente para tratamiento de heridas.

Country Status (11)

Country Link
US (1) US20210001003A1 (es)
EP (1) EP3717028A1 (es)
JP (1) JP2021504020A (es)
KR (1) KR20200093600A (es)
CN (1) CN111867641A (es)
AU (1) AU2018375280A1 (es)
BR (1) BR112020008574A2 (es)
CA (1) CA3079753A1 (es)
MX (1) MX2020005101A (es)
SG (1) SG11202003606SA (es)
WO (1) WO2019108497A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113057960B (zh) * 2021-04-15 2022-06-21 浙江理工大学 β-环糊精类衍生化合物在制备促进伤口愈合药物或制剂中的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5502042A (en) * 1994-07-22 1996-03-26 United States Surgical Corporation Methods and compositions for treating wounds
US7435425B2 (en) * 2001-07-17 2008-10-14 Baxter International, Inc. Dry hemostatic compositions and methods for their preparation
CA2350628A1 (en) * 1998-11-12 2000-05-18 Polymer Biosciences, Inc. Hemostatic polymer useful for rapid blood coagulation and hemostasis
MXPA04006438A (es) * 2001-12-31 2005-06-08 Ares Lab Llc Composiciones hemostaticas y metodos para el control de sangrado.
SA111320355B1 (ar) * 2010-04-07 2015-01-08 Baxter Heathcare S A إسفنجة لايقاف النزف
CN103998068B (zh) * 2011-10-11 2016-05-25 巴克斯特国际公司 止血组合物
SG11201704537QA (en) * 2014-12-19 2017-07-28 Baxter Int Flowable hemostatic composition
CN106581738A (zh) * 2016-12-09 2017-04-26 苏州纳贝通环境科技有限公司 一种超吸水医用复合止血海绵及其制备方法

Also Published As

Publication number Publication date
CA3079753A1 (en) 2019-06-06
AU2018375280A1 (en) 2020-06-11
WO2019108497A1 (en) 2019-06-06
CN111867641A (zh) 2020-10-30
SG11202003606SA (en) 2020-05-28
US20210001003A1 (en) 2021-01-07
EP3717028A1 (en) 2020-10-07
BR112020008574A2 (pt) 2020-10-20
JP2021504020A (ja) 2021-02-15
KR20200093600A (ko) 2020-08-05

Similar Documents

Publication Publication Date Title
MX2022004874A (es) Compuestos de modulacion de glp-1r.
MX2020012028A (es) Metodos y composiciones para tratar el cancer.
MX2020012797A (es) Anticuerpos biespecificos anti-pvrig/anti-tigit y métodos de uso.
MX2021006681A (es) Anticuerpos anti-claudina y usos de los mismos.
MX2020009313A (es) Composiciones y metodos para renovacion de la piel.
MX2018011811A (es) Apositos para heridas modificados.
CL2023003068A1 (es) Compuestos, composiciones y métodos para el tratamiento de trastornos
MX2020013557A (es) Un esteroide de c21-pirazolilo disustituido con 19-nor c3,3 y métodos de uso del mismo.
RS54525B1 (en) DLBCL TREATMENT MEANS AND PROCEDURES
WO2019048715A3 (en) COMPOSITIONS CONTAINING A BIOMASS COMPOSITION CONTAINING ACTIVATED PECTIN, AND METHODS FOR PREPARING SUCH COMPOSITIONS
MX2019011506A (es) Inhibicion de cinasa 1 de punto de control (chk1) para el tratamiento de cancer.
WO2019051327A3 (en) BETA CATENIN FUNCTIONALIZATION AGENTS AND ASSOCIATED METHODS
MX2023012418A (es) Compuestos de modulacion de glp-1r de carboxi-bencimidazol.
MX2023012419A (es) Compuestos moduladores de glp-1r de carboxi-bencimidazol.
MX2023004869A (es) Anticuerpos contra sars-cov-2 y usos de los mismos.
GB2556735A (en) Weighted composition for treatment of a subterranean formation
CL2021000496A1 (es) Gel de partículas de reticulación para el control de conformidad de co2 y bloqueo de filtración de co2.
MX2022008099A (es) Tratamiento para el cancer con inhibidores de cdk12/13.
MX2021008906A (es) Formulacion pesticida que comprende mfc como modificador de reologia.
MX2020005101A (es) Absorbente para tratamiento de heridas.
MX2019009759A (es) Composiciones de peptido estables.
WO2020146700A8 (en) Lipid nanoparticles
MX2021007160A (es) Una semilla de planta artificial y usos de esta.
MX2020009496A (es) Metodo para tratar asma o enfermedad alergica.
PH12021550121A1 (en) Methods of treating hfpef employing dapagliflozin and compositions comprising the same